{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:08:37Z","timestamp":1774876117115,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10,1]]},"DOI":"10.2146\/ajhp140804","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T16:17:36Z","timestamp":1442593056000},"page":"1623-1629","source":"Crossref","is-referenced-by-count":12,"title":["Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence"],"prefix":"10.1093","volume":"72","author":[{"given":"Kyle A.","family":"Davis","sequence":"first","affiliation":[{"name":"Jackson Memorial Hospital, Miami, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta A.","family":"Miyares","sequence":"additional","affiliation":[{"name":"Jackson Memorial Hospital, Miami, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Department of Community Health and Family Medicine, College of Medicine, and Clinical Assistant Professor, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041102114123600_b1-0721623","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041102114123600_b2-0721623","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041102114123600_b3-0721623","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"key\n\t\t\t\t2019041102114123600_b4-0721623","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041102114123600_b5-0721623","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"issue":"suppl 2","key":"key\n\t\t\t\t2019041102114123600_b6-0721623","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"suppl 1","key":"key\n\t\t\t\t2019041102114123600_b7-0721623","first-page":"S34","article-title":"Update on lipids, inflammation and atherothrombosis","volume":"105","author":"Badimon","year":"2011","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t2019041102114123600_b8-0721623","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/joim.12296","article-title":"Thrombosis formation on atherosclerotic lesions and plaque rupture","volume":"276","author":"Badimon","year":"2014","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t2019041102114123600_b9-0721623","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/asheducation-2011.1.51","article-title":"The role of platelets in atherothrombosis","volume":"2011","author":"Kaplan","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"key\n\t\t\t\t2019041102114123600_b10-0721623","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13311-011-0060-2","article-title":"Antiplatelet agents for stroke prevention","volume":"8","author":"Yip","year":"2011","journal-title":"Neurotherapeutics"},{"key":"key\n\t\t\t\t2019041102114123600_b11-0721623","volume-title":"Plavix (clopidogrel bisulfate) package insert","year":"2013"},{"key":"key\n\t\t\t\t2019041102114123600_b12-0721623","first-page":"CD000029","article-title":"Antiplatelet therapy for acute ischemic stroke","volume":"3","author":"Sandercock","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041102114123600_b13-0721623","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041102114123600_b14-0721623","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/CIRCULATIONAHA.106.653741","article-title":"Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?","volume":"115","author":"Liao","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041102114123600_b15-0721623","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/0003319713499609","article-title":"Antiplatelet treatment in the secondary prevention of coronary and cerebrovascular disease: is there any place for novel agents?","volume":"65","author":"Ntalas","year":"2013","journal-title":"Angiology"},{"key":"key\n\t\t\t\t2019041102114123600_b16-0721623","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/hs0402.105246","article-title":"Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease","volume":"33","author":"Vickrey","year":"2002","journal-title":"Stroke"},{"key":"key\n\t\t\t\t2019041102114123600_b17-0721623","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041102114123600_b18-0721623","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041102114123600_b19-0721623","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041102114123600_b20-0721623","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041102114123600_b21-0721623","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041102114123600_b22-0721623","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","article-title":"Fast Assessment of Stroke and Transient Ischaemic Attack to Prevent Early Recurrence (FASTER): a randomised controlled pilot trial","volume":"6","author":"Kennedy","year":"2007","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t2019041102114123600_b23-0721623","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"Benavente","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041102114123600_b24-0721623","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041102114123600_b25-0721623","unstructured":"ClinicalTrials.gov. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trial. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00991029 (accessed 2014 Oct 28)."},{"key":"key\n\t\t\t\t2019041102114123600_b26-0721623","unstructured":"ClinicalTrials.gov. Combination of Clopidogrel and Aspirin for Prevention of Early Recurrence in Acute Atherothrombotic Stroke (COMPRESS). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00814268 (accessed 2014 Oct 29)."},{"key":"key\n\t\t\t\t2019041102114123600_b27-0721623","unstructured":"ClinicalTrials.gov. Triple Antiplatelets for Reducing Dependency After Ischemic Stroke (TARDIS). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01661322 (accessed 2014 Oct 30)."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/72\/19\/1623\/28339096\/ajhp1623.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T18:48:03Z","timestamp":1567190883000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/72\/19\/1623\/5111748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":27,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2015,10,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp140804","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,10,1]]},"published":{"date-parts":[[2015,10,1]]}}}